Freestone Grove Partners’s Innospec IOSP Stock Holding History
Bought
Maintained
Sold
Other funds holding IOSP
Freestone Grove Partners's IOSP Position: Q2 2026 in Review
Freestone Grove Partners reduced its Innospec (IOSP) stake by 32% in Q2 2026, selling an estimated $263K and leaving 7,189 shares worth $585K. The position accounts for ﹤0.01% of the portfolio, ranked #629.
Freestone Grove Partners first reported a position in IOSP in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.03M in Q4 2025. 282 funds tracked by Wall St. Rank hold IOSP as of Q2 2026.
- Freestone Grove Partners held 7,189 shares of Innospec worth $585K as of Q2 2026.
- Freestone Grove Partners sold 3,322 Innospec shares in Q2 2026, an estimated $263K.
- Innospec made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #629 holding.
- Freestone Grove Partners first reported a position in Innospec in Q2 2025 and has held it in 5 quarters since.
- Freestone Grove Partners's Innospec position peaked at $1.03M in Q4 2025.
- 282 funds tracked by Wall St. Rank held Innospec as of Q2 2026.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.